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Mutations in the filaggrin gene (Flg) are associated with increased systemic levels of 
Th17 cells and increased IL-17A production following antigen exposure in both humans 
and mice. In addition to Th17 cells, γδ T cells can produce IL-17A. The differentiation 
of γδ T cells to either IFNγ or IL-17A-producing (γδT17) cells is mainly determined in the 
thymus. Interestingly, it has been reported that filaggrin is expressed in the Hassall bodies 
in the human thymic medulla. However, whether filaggrin affects γδ T cell development is 
not known. Here, we show that filaggrin-deficient flaky tail (ft/ft) mice have an increased 
number of γδT17 cells in the spleen, epidermis, and thymus compared to wild-type (WT) 
mice. We demonstrate that filaggrin is expressed in the mouse thymic medulla and that 
blocking the egress of cells from the thymus results in accumulation of Vγ2+ γδT17 cells 
in the thymus of adult ft/ft mice. Finally, we find increased T cell receptor expression 
levels on γδ T cells and increased levels of IL-6 and IL-23 in the thymus of ft/ft mice. 
These findings demonstrate that filaggrin is expressed in the mouse thymic medulla and 
that production of Vγ2+ γδT17 cells is dysregulated in filaggrin-deficient ft/ft mice.
Keywords: ft/ft mice, filaggrin, γδ T cells, il-17, thymus, development
inTrODUcTiOn
Filament aggregating protein (filaggrin) is a major structural skin protein that assists in the for-
mation of the epidermal barrier. Filaggrin is a degradation product from the large pro-protein 
profilaggrin (>400 kDa). During terminal differentiation of keratinocytes, profilaggrin is carried 
apically, dephosphorylated and degraded into an N-terminal peptide, several filaggrin monomers 
and a C-terminal peptide (1, 2). The flaky tail (ft/ft) mouse is commonly used as a model of filag-
grin deficiency exhibiting spontaneous development of eczematous skin lesions (3). The increased 
skin inflammation in filaggrin-deficient mice correlates with increased levels of IL-17A (4, 5). 
Abbreviations: DETC, dendritic epidermal T cells; Flg, filaggrin gene; ft, flaky tail; TCR, T cell receptor; TEC, thymic epithelial 
cells; TSC, thymic stromal cells; WT, wild type; γδT17, 17-producing γδ T cells.
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Accordingly, a strong reduction of skin inflammation is seen in 
IL-17A/filaggrin double-deficient mice compared to mice only 
deficient in filaggrin (6). In addition to the local IL-17A-driven 
skin inflammation, a systemic OVA-specific IL-17A response can 
be induced in filaggrin-deficient mice by exposure of the skin to 
OVA (3, 4). In line with this, we have recently shown that filaggrin 
deficiency is associated with an increase in the numbers of IL-17-
producing T (Th17) cells in both humans and mice (7). Whether 
filaggrin deficiency affects other IL-17A-producing cell subsets is 
currently unknown.
γδ T cells can be divided into IFN-γ or IL-17-producers. The 
master transcriptional regulators of IFNγ and IL-17-producing 
γδ T (γδT17) cells are the T-box transcription factor (T-bet) 
and retinoic acid receptor-related orphan receptor-γt (RORgt), 
respectively (8). Whereas γδ T  cells leave the thymus as naïve 
T cells and gain their effector function upon priming in periph-
eral lymphoid tissues, the effector fate of γδ T cells is mainly pro-
grammed in the thymus (9–12). The γδT17 cells can be divided 
into two groups: natural γδT17 cells, which are programmed for 
IL-17 production during their development in the thymus, and 
inducible γδT17 cells, which are primed for IL-17 production 
after leaving the thymus (9–13).
γδ T cells develop in distinct waves characterized by different 
Vγ segment usage (14). γδ T cells expressing Vγ1.1, Vγ3, or Vγ5 
segments [Garman nomenclature (15)] primarily become IFN-γ 
producing cells, while γδ T cells expressing Vγ4 primarily become 
IL-17-producing cells. Interestingly, γδ T  cells expressing the 
Vγ2 segment can develop into either IFNγ or IL-17-producing 
cells. Different signaling pathways determine whether a γδ T cell 
in the thymus will become IFNγ or IL-17 producing. Both T cell 
receptor (TCR)-dependent and TCR-independent signaling 
pathways are involved in γδ T cell development. Different subsets 
of thymic epithelial cells (TEC) provide the microenvironments 
needed for the development of T cells. Interestingly, it has been 
reported that terminally differentiated TEC in the Hassall’s 
corpuscles in the human thymic medulla express filaggrin. 
The important role of TEC in the development of conventional 
T  cells is well described, but the role of TEC in the develop-
ment of γδ T cells is less clear. However, it is believed that TEC 
provide distinct ligands or selecting molecules modulating the 
thymic programming of γδ T cells. Strong TCR signaling induces 
development of IFNγ producing cells, whereas missing or weak 
TCR signaling leads to development of γδT17 cells (9, 10, 16). 
In addition to TCR signaling, signaling via costimulatory recep-
tors and cytokine receptors also affects γδ T cell development 
(11, 17–19). Signaling via CD27 seems to play an important role 
in the differentiation of γδ T cells in thymus as CD27+ γδ T cells 
differentiate into IFNγ-producing cells, whereas CD27−γδ T cells 
become IL-17 producing (11). Finally, the cytokine environment 
in the thymus regulates the differentiation of γδ T cells. TGFβ, 
IL-1, IL-23, and IL-6 seem to mediate the development of IL-17-
producing γδ T cells (17).
In the present study, we investigated whether the production 
of γδ T cells is affected in filaggrin-deficient ft/ft mice. We found 
a fivefold increase of splenic and epidermal γδT17 cells in ft/ft 
mice compared to wild-type (WT) mice. This increase of γδT17 
cells was associated with an enhanced production of γδT17 cells 
in the thymus. In addition, we found that filaggrin is expressed 
in the thymus medulla of WT mice and that filaggrin expression 
is reduced in the thymus of ft/ft mice. Further analyses showed 
that the increased number of γδT17 cells was primarily contained 
within the Vγ2+ subset. Finally, we found higher TCR expression 
levels on γδ thymocytes and higher levels of IL-6 and IL-23 in the 
thymus of ft/ft mice compared to WT mice.
MaTerials anD MeThODs
animal Model
Flaky tail mice (a/a Tmem79ma Flgft/J, stock number 000281) 
(ft/ft) were purchased as cryopreserved embryos from the 
Jackson Laboratory and bred at our in-house animal facility. 
Age-matched, mixed gender C57Bl/6 mice were purchased from 
Janvier or Taconic Laboratories. Experiments were performed 
on the mice at the age of 8–12 weeks. The mice were housed in 
the specific pathogen free animal facility at the Department of 
Experimental Medicine, Panum Institute, in accordance with the 
national animal protection guidelines (license number 2012-15-
2934-00663). C57Bl/6 mice were used as WT controls as ft/ft mice 
have previously been described to be outcrossed onto C57Bl/6 
mice. However, ft/ft is not a strict congenic strain, but a semi-
inbred strain (5). In some experiments, mice were treated with 
FTY720 (2.5 µg/ml) in their drinking water for six consecutive 
days.
Preparation of single-cell suspensions
Single-cell suspensions from thymi, lymph nodes, and spleens 
were prepared by dissociating the organs on 70 µm cell strain-
ers. The single cells were washed in RPMI medium (10% FBS, 
0.5 IU/L penicillin, 500 mg/L streptomycin, 1% l-glutamine), and 
cell suspensions were adjusted to 2 × 107 cells/mL. Subsequently, 
100  μL/well was plated in a round-bottomed 96-well plate. 
Single-cell suspensions from the epidermis were isolated from 
the ears. The ears were split into a dorsal and ventral part. The 
dorsal part was transferred to a 0.3% trypsin-GNK (2.94  g 
NaCL, 0.134 g KCl, 0.334 g glucose/dextrose per 1 g of trypsin) 
solution for 60 min at 37°C, 5% CO2 with the dermis side down. 
The epidermis was peeled from the dermis and transferred to 
0.3% trypsin-GNK with 0.1% DNase and left at 37°C for 10 min. 
Cells were filtered through a cell strainer, washed and plated 
overnight at 37°C, 5% CO2 to allow re-expression of surface 
markers.
staining and Flow cytometry
Fc-receptors were blocked with anti-CD16/CD32. Surface mark-
ers on cells were stained with anti-CD3ε, -TCRγδ(GL3), -CD4, 
-CD8α, -CD24, -CD25, -CD44, -CD27, CD45RB, -CCR6, -Vγ1, 
-Vγ2, and -Vγ3 diluted in Brilliant Stain Buffer (BD Biosciences). 
Viability of cells was determined using Fixable Viability Dye 
(eFlour® 780) (eBioscience). When staining for intracellular 
cytokines, the cells were first stimulated with PMA (50 ng/ml), 
monensin sodium (4 µg/ml), and ionomycin (500 ng/ml) for 4 h 
and stained for surface markers. Following fixation and permea-
bilization with BD Cytofix/Cytoperm (BD Biosciences), the cells 
were stained for intracellular cytokines with anti-IL-17A and 
3Jee et al. Dysregulated Thymocyte Production in Filaggrin-Deficient Mice
Frontiers in Immunology | www.frontiersin.org May 2018 | Volume 9 | Article 988
anti-IFNγ antibodies. Data were collected on a BD LSRFortessa 
and analyzed with FlowJo Software.
histology and staining for confocal 
Microscopy
Ears and thymi from ft/ft and C57Bl/6 mice were transferred 
to formaldehyde. Histology was performed by Nordic Biosite, 
Finland. Sections were stained with hematoxylin and eosin and 
with antibodies targeting filaggrin (Poly19058, BioLegend).
For confocal microscopy analyses, fresh thymi were imbed-
ded in OCT compound (Sakura Fintek) and snap frozen on dry 
ice. The tissue was cut into 7 µm sections and fixed in acetone. 
The following antibodies were used for staining: rabbit anti-
filaggrin (Poly19058, BioLegend), AlexaFluor 647 anti-mouse 
CD4 (GK1.5, BioLegend), and biotinylated anti-mouse CD8a 
(53-6.7, eBioscience). To detect the anti-filaggrin antibody, an 
AlexaFluor 555 donkey anti-rabbit IgG (Invitrogen) antibody was 
used. Biotinylated CD8 antibody was detected with Streptavidin 
conjugated to AlexaFluor 488 (Life Technologies). Purified rabbit 
polyclonal isotype control (Poly19058, Biolegend) was used as 
control to filaggrin stains. Sections were analyzed using a Zeiss 
LSM 880 confocal microscope.
Quantitative real-Time Pcr
Organs frozen in liquid nitrogen were disintegrated in a Precellys 
tissue homogenizer (Bertin Technologies) in 500–1,000  mL of 
TRI Reagent (Sigma Aldrich). For RNA extraction from thymic 
stromal cells (TSC), fresh thymi were cut into 6–8 pieces and 
thymocytes mechanically released by pipetting and changing of 
medium, and finally disintegrated as described above. Following 
centrifugation, the supernatant was mixed with 1-Bromo-3-
chloropropane (Sigma Aldrich), samples were centrifuged 
and the upper phase recovered. RNA isolation was performed 
using the RNeasy Mini Kit 250 (Qiagen) according to manufac-
turer’s specifications. RNA concentrations were measured using 
a Nanodrop 2000c spectrophotometer (Thermo Scientific), and 
RNA was diluted to a final concentration of 2 µg/µL. RNA was 
transcribed into cDNA using the RevertAid First Strand cDNA 
Synthesis Kit (Fermentas). Transcription of genes was measured 
by real-time PCR. Stock Taqman primer/probe sets with Taqman 
Universal Master Mix was processed in a Stratagene Mx3000P/
Mx3005P (AH Diagnostics/Agilent Technologies), and the data 
was analyzed using MxPro software. Transcription of target genes 
was calculated relatively to GAPDH.
Protein extraction
Extraction of protein was performed by lysing ears with lysis 
buffer (50 mM Tris Base, 250 mM NaCl, 5 mM EDTA, 1% Triton 
X-100), and disintegrating the samples on a Precellys tissue 
homogenizer (Bertin Technologies). Subsequently, samples were 
spun down, and the supernatant was recovered. To purify TSC, 
thymi were cut into 6–8 pieces, and the thymocytes were mechani-
cally released by pipetting up and down with a 1,000 µl pipette 
tip with the outermost end trimmed off. Following removal of 
media containing the thymocytes, fresh media was added and 
the release of thymocytes was repeated two times. TSC were lysed 
and protein extracted as described above.
elisa
Protein lysates were adjusted to a concentration of 3.0  µg/µl 
following determination of concentration by Bradford assay. 
Concentrations of IL-6 and IL-23 were determined using 
Mouse IL-6 ELISA Ready-SET-Go and mouse IL-23 ELISA 
Ready-SET-Go kits (eBioscience) according to manufacturer’s 
specifications.
statistical analysis
Differences between groups were evaluated by the two-tailed 
unpaired Student’s t-test. The statistical analysis was performed 
using GraphPad Prism version 6.0, and a p-value below 0.5 was 
considered statistically significant. Statistical significance p-values 
are denoted as: *<0.05, **<0.01, ***<0.001, ****<0.0001.
resUlTs
ft/ft Mice have increased numbers of 
γδT17 cells in the spleen and epidermis
To investigate whether γδ T cells might be involved in the IL-17 
driven immune responses in ft/ft mice, we examined the distribu-
tion of γδ T cells in the spleen of ft/ft and WT (C57Bl/6) mice. 
The percentages as well as the absolute numbers of γδ T  cells 
were significantly increased in ft/ft mice compared to WT mice 
(Figures 1A,B). Next, we investigated whether the increase of γδ 
T  cells in the spleen of ft/ft mice also resulted in an increased 
number of γδT17 cells by determining the number of γδ T cells 
expressing IL-17A. We found significantly increased percent-
ages and absolute numbers of γδ T  cells expressing IL-17A in 
the spleen of ft/ft mice compared to WT mice (Figures 1C,D). 
Interestingly, this increase was specific for IL-17A-producing 
cells as no significant differences were seen in the percentages 
or numbers of IFN-γ-producing γδ T cells between ft/ft and WT 
mice (Figures 1E,F). The elevated number of IL-17A-producing 
cells seen in ft/ft mice seemed to be specific for γδ T cells and 
CD4+ T  cells, as no differences in the frequencies of IL-17A-
producing CD8+ T cells or non-T cells were observed between 
ft/ft and WT mice (Figures S1–S3 in Supplementary Material). 
Expression of CD27, CD45RB, and CCR6 can be used to deter-
mine γδ T cell subsets that produce IL-17A or IFN-γ (11, 13, 20). 
We found significantly increased fractions of CD27−CD45RB− or 
CD27−CCR6+ splenic γδ T cells in ft/ft mice (Figures 1G,H) in 
agreement with the observation described above. To determine if 
the accumulating γδT17 cells were restricted to a specific subset 
of γδ T cells in the spleen of ft/ft mice, we co-stained for IL-17A 
and Vγ1.1 or Vγ2. The increased fraction of IL-17A+ cells seemed 
to be restricted to the Vγ2+ subset (Figures 1I,J). As ft/ft mice 
develop spontaneous skin inflammation (3), we next wanted to 
determine if elevated numbers of γδT17 cell also were found in 
the epidermis of ft/ft mice. We found a highly increased fraction 
of Vγ2+ T cells as well as an increased fraction of Vγ3+ T cells, 
the major T cell subset within epidermis, that were IL-17A+ in 
the epidermis of ft/ft mice compared to WT mice (Figures 1K,L). 
Taken together, these data indicated that the peripheral γδ T cell 
population, including γδT17 cells, is significantly expanded in 
ft/ft mice compared to WT mice.
FigUre 1 | Increased numbers of γδT17 cells in the spleen and epidermis of ft/ft mice. (a–J) Flow cytometric analyses of spleen cells from 8 to 12 weeks old 
C57Bl/6 and ft/ft mice. (a) Fraction of CD3ε+TCRγδ+ spleen cells. (B) Absolute numbers of CD3ε+TCRγδ+ spleen cells. (c–F) Fraction and absolute numbers of 
(c,D) IL-17+ and (e,F) IFN-γ+ TCRγδ+ cells. (g,h) Dot plots showing CD27 versus CD45RB and CD27 versus CCR6 expression of TCRγδ+ cells. (i,J) Plots showing 
IL-17 expression on TCR Vγ1.1+ or TCR Vγ2+. (K,l) Plots showing IL-17 expression on TCR Vγ2+ and TCR Vγ3+ cells from the epidermis. Data are representative of 
two to three independent experiments with three to four mice in each. The mean percentages ± SD are given for the relevant populations in the plots.
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FigUre 2 | Increased numbers of γδT17 cells in the thymus of ft/ft mice. (a–h) Flow cytometric analyses of thymocytes from 8 to 12 weeks old C57Bl/6 and ft/ft 
mice. (a) Plots showing CD4 and CD8 staining of total thymocytes. The total numbers of thymocytes are given above the plots. (B) Plots showing CD25 and CD44 
staining on the double negative CD4−CD8− thymocyte population. (c,D) Fraction and absolute numbers of CD3ε+TCRγδ+ thymocytes. (e,F) Fraction and absolute 
numbers of IL-17+ TCRγδ+ thymocytes. (g,h) Dot plots showing CD27 versus CD45RB and CD27 versus CCR6 expression of TCRγδ+ thymocytes. Data are 
representative of two to four independent experiments with two to four mice in each. The mean percentages ± SD are given for the relevant populations in the plots.
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ft/ft Mice have increased numbers of 
γδT17 cells in the Thymus
To establish whether the increased number of γδT17 cells found 
in the peripheral lymphoid organs of ft/ft mice originated from 
natural γδT17 cells programmed in the thymus, we investigated 
the cellular distribution in the thymus of ft/ft and WT mice. We 
found no significant differences between ft/ft and WT mice in the 
fraction of double positive (CD4+CD8+), CD4 single positive and 
CD8 single positive cells or in the double negative (CD4−CD8−) 
1–4 fractions (CD44+CD25−, CD44+CD25+, CD44−CD25+ and 
CD44−CD25+, respectively) (Figures 2A,B). However, ft/ft mice 
on average had a 20% increase in their total numbers of thymo-
cytes as compared to WT mice (Figure 2A). Next, we analyzed the 
γδ T cell populations. We observed a significantly larger popula-
tion of γδ T cells in the thymi of ft/ft mice compared to WT mice, 
which primarily was caused by the general increase in cell numbers 
in the thymi of ft/ft mice compared to WT mice (Figures 2C,D). 
Despite the similar fraction of total γδ T cells, we found a significant 
FigUre 3 | Decreased filaggrin expression at the transcriptional level in the 
thymus of ft/ft mice. (a–c) Immunohistological analyses of ears and thymi 
from 8 to 12 weeks old C57Bl/6 and ft/ft mice. Sections of (a) ears and (B) 
thymi were stained with anti-filaggrin antibody. The sections are magnified 
×200 and the bars indicate 0.1 mm. (c) Confocal microscopy images of 
thymi showing expression of CD4 (green), CD8 (blue), and filaggrin (red). The 
bars indicate 200 µm. (D) Relative profilaggrin transcription in the skin, thymic 
stromal cells (TSC), and lymph nodes of ft/ft and C57Bl/6 mice. The 
Ct-values of profilaggrin transcription were normalized to the transcription of 
GAPDH. The means (n = 6) are indicated by bars. For C57Bl/6 lymph nodes, 
three values of profilaggrin transcription were zero and are therefore not 
indicated with dots on the logarithmic scale. Expression of profilaggrin of TSC 
was compared to skin and lymph nodes for each group.
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increase in both the fraction and the total numbers of γδ T cells 
expressing IL-17A in ft/ft compared to WT mice (Figures 2E,F). 
In accordance with this, we found a significant increase in the 
fraction of CD27−CD45RB− (Figure  2G) and CD27−CCR6+ γδ 
T cells (Figure 2H) in ft/ft compared to WT mice.
Filaggrin is expressed in the Thymic 
Medulla of Mice
Next, we speculated whether filaggrin is expressed in the thymus 
of mice and thereby could affect γδ T  cell development. In 
humans, filaggrin is expressed in the Hassall’s corpuscles (21, 22), 
but it is unknown whether filaggrin is expressed in the thymus 
of mice. To determine the expression and location of filaggrin 
in the thymus, we compared thymi of ft/ft mice and WT mice 
using immunohistochemistry. Skin was used as a positive control 
(Figure 3A). Interestingly, we found that filaggrin is expressed in 
small clusters of cells in the thymic medulla in WT mice, and to a 
lesser extend in the thymic medulla of ft/ft mice (Figures 3B,C). 
The ft mutation carried by the ft/ft mice is a frameshift mutation 
that results in the expression of a truncated profilaggrin and 
almost complete absence of filaggrin monomers in the epidermis 
of ft/ft mice (3). Thus, the mutation does not necessarily cause a 
decreased transcription of Flg. We found that filaggrin is tran-
scribed in thymic stroma of both ft/ft and WT mice, but to a lesser 
degree than seen in skin (Figure 3D). Furthermore, we found an 
approximately threefold reduction in the transcription of filag-
grin in the TSC of ft/ft mice compared to WT mice (Figure 3D). 
Taken together, these data show that filaggrin is expressed at the 
protein and RNA level in the thymic medulla of WT and ft/ft mice 
and that the expression is lower in ft/ft mice.
γδT17 cells continue to Be Produced after 
Birth in the Thymus of ft/ft Mice
It has been described that natural γδT17 cells normally are 
produced only during fetal stages (12, 23). To determine whether 
the increase of γδT17 cells in the thymus of ft/ft mice was a 
reminiscence from the fetal stage or was due to an ongoing 
development during adulthood, we analyzed mice treated with 
FTY720, an inhibitor of S1P-R1-mediated thymic egress (24). The 
total numbers of γδ T cells were significantly higher in both ft/ft  
and WT thymus following FTY720 treatment. However, in ft/ft  
mice, the accumulation of γδ T  cells was significantly greater 
than in WT mice (Figure 4A). Consistent with previous studies 
(12, 23), adult WT mice did not accumulate γδT17 cells follow-
ing FTY720 treatment (Figure 4B). However, in contrast to WT 
mice, we found that ft/ft mice accumulated γδT17 cells in the 
thymus when treated with FTY720 (Figure 4B). This difference 
was specific to γδT17 cells as IFNγ+ γδ T cells accumulated to the 
same degree in ft/ft and WT mice (Figure 4C). To determine if 
the accumulating γδT17 cells were restricted to a specific subset 
of γδ T cells in the ft/ft thymi, we co-stained with Vγ1.1, Vγ2, 
and Vγ3. No significant accumulation of Vγ1.1+ or Vγ3+ γδT17 
cells was detected (Figures  4D,E), whereas Vγ2+ γδT17 cells 
accumulated significantly (Figures 4F,G). As the accumulation 
of Vγ2+ γδT17 cells only accounted for approximately 50% of the 
total number of accumulated γδT17 cells in the thymus of ft/ft 
mice other γδT cell subsets, most likely Vγ4+ γδT17, probably 
also accumulated. Taken together, these experiments indicated 
that production of Vγ2+ γδT17 cells is dysregulated in ft/ft mice 
and that Vγ2+ γδT17 cells continue to be produced in the thymus 
of adult ft/ft mice.
FigUre 4 | ft/ft mice accumulate γδT17 cells in the adult thymus. Numbers of γδTCR cells and γδTCR subsets in the thymus of 8–12 weeks old ft/ft and C57BL/6 
mice treated with FTY720 or untreated. Single-cell suspensions were stained with anti-TCRγδ, -TCRβ, -IL-17A, –IFN-γ. -Vγ1.1, -Vγ2, and -Vγ3. Percentages of each 
population were multiplied with the cell count of the parent gate to get the numbers presented. (a) Numbers of γδTCR cells. (B) Numbers of IL-17A+ γδTCR cells. 
(c) Numbers of IFN-γ+ γδTCR cells. (D) Numbers of Vγ1.1+IL-17A+ γδTCR cells. (e) Numbers of Vγ3+IL-17A+ γδTCR cells. (F,g) Numbers and percentage of 
Vγ2+IL-17A+ γδTCR cells.
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increased levels of il-6 and il-23 in the 
Thymus of ft/ft Mice
The exact mechanisms determining the effector fate of γδ T cells 
in the thymus have yet to be fully uncovered, but antigen-naïve 
γδ T cells have been shown to produce IL-17, whereas antigen-
experienced γδ T cells produce IFNγ (10). As the TCR expres-
sion level has been suggested to be a marker for whether the γδ 
T  cells have encountered antigen or not (10), we determined 
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the TCR expression levels on thymic γδ T  cells from ft/ft and 
WT mice. In accordance, with the increased number of γδT17 
T  cells, we found higher expression levels of both TCRγδ and 
CD3εon thymic γδ T cells in ft/ft mice compared to WT mice 
(Figures  5A–D). To further investigate possible mechanisms 
mediating the increased development of γδT17 cells in ft/ft mice, 
FigUre 5 | Continued
FigUre 5 | Altered TCR expression and cytokine expression in ft/ft mice. Representative histograms of (a) CD3ε and (B) TCRγδ expression on thymocytes from 8 
to 12 weeks old wild-type (WT) (dashed lines) and ft/ft (red filling) mice. Mean fluorescence intensity (MFI) of (c) CD3ε and (D) γδTCR expression. (e–h) Relative 
gene expression of IL1B, IL6, IL23, and TGFB1 in the thymi from ft/ft and WT mice. The Ct-values of the specific gene transcription were normalized to the 
transcription of GAPDH. (i,J) Concentrations of IL-6 and IL-23 in thymic lysates from ft/ft and WT mice.
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we analyzed the expression of factors known to be involved in 
the differentiation of γδ T  cells and Th17  cells. Interestingly, 
we found a significantly increased  transcription of IL6 and 
IL23A, but not of IL1B and TGFB1 in ft/ft mice compared to 
WT (Figures 5E–H). Accordingly, we found significantly higher 
protein levels of IL-6 and IL-23 in ft/ft mice compared to WT 
(Figures 5I,J).
DiscUssiOn
In this study, we show that adult ft/ft mice have an increased 
number of γδT17 cells in the thymus, spleen and epidermis com-
pared to WT mice. Furthermore, we demonstrate that filaggrin 
is expressed by TSC in the thymic medulla of WT mice and that 
this expression is decreased at both the transcriptional and trans-
lational level in the thymus of ft/ft mice. Blocking thymic egress 
resulted in an accumulation of Vγ2+ γδT17 cells in ft/ft mice, 
which was not seen in WT mice. Finally, we found an increased 
TCR expression level on thymic γδ T cells and an increased level 
of IL-6 and IL-23 in the thymi of ft/ft mice compared to WT 
mice.
The spontaneous skin inflammation found in ft/ft mice cor-
relates with increased levels of IL-17A in the skin (4). In agree-
ment with this, we found increased numbers of γδT17 cells in the 
epidermis of ft/ft mice compared to WT mice. Interestingly, we 
found that the majority of γδT17 cells in epidermis of ft/ft mice 
belonged to the Vγ2 subset, which are normally not present in 
the epidermis. In addition to the mutation in the Flg gene, ft/ft 
mice also have a mutation in the Tmem79 gene. Therefore, we 
cannot exclude the possibility that the Tmem79 gene plays a role 
in the increased number of γδT17 cells in the ft/ft mice. However, 
an increased level of IL-17A has been found in the skin of pure 
filaggrin-deficient mice supporting the importance of the Flg 
gene in γδT17 cell homeostasis (25).
Thymic crosstalk is the term used to describe the bidirectional 
need of TEC for development of T  cells and of T  cells for the 
development of TEC. In WT mice, γδT17 cells are only produced 
in the fetal thymus (12). In contrast, we show that γδT17 cells still 
are produced in the thymus of adult ft/ft mice. The mechanisms 
behind this are still unclear. However, distinct programs of thymus 
epithelial cell development exist in the fetal and adult thymus. 
Thus, the ability of the adult ft/ft thymus to continue to produce 
a γδ T cell subset typical of the embryonic thymus could indicate 
that the switch from fetal to adult programmes of TEC develop-
ment are disturbed in ft/ft mice. Relevant to this, filaggrin expres-
sion in human thymus maps to Hassall’s corpuscles, a product of 
mTEC terminal differentiation that is first evident in mice after 
birth (26). Thus, filaggrin may be required for an mTEC terminal 
differentiation programme that marks age-related changes in the 
thymic microenvironment, which then controls the ability of the 
thymus to support different programs of T cell development at 
specific developmental stages.
The γδTCR signaling strength determines which effector sub-
set the thymic γδ T cells will commit to; strong γδTCR signaling 
results in development of IFN-γ producing cells and weak signal-
ing in IL-17A producing cells (9–11, 16). A central regulator of 
TCR signaling in thymic γδ T cells is the TCR expression level 
(27). Mice with reduced TCR expression level on their thymic γδ 
T cells have reduced TCR signaling and increased development 
of γδT17 cells compared to WT mice (27). Based on this, one 
could suspect that the increased TCR expression level we find on 
thymic γδ T cells in the ft/ft mice compared to WT mice would 
result in an increased generation of IFN-γ producing γδ T cells. 
In contrast, we found increased levels of γδT17 cells in both the 
thymus and periphery of ft/ft mice. However, increased TCR 
expression levels are found on thymic γδT cells in mice where 
the TCR ligand is not expressed compared to mice where the TCR 
ligand is expressed and lack of TCR ligand expression correlated 
with increased development of γδT17 cells (10). Furthermore, 
it is well described that T cells down-regulate the TCR on their 
surface as part of T cell activation (28). It is therefore possible 
that the increased TCR expression found on thymic γδ T cells 
in the ft/ft mice is due to reduced expression of TCR ligand in 
these mice. Although our observations indicate that the develop-
ment of Vγ2+ γδT17 cells is dysregulated in ft/ft mice, we cannot 
formally exclude that the increased numbers and accumulation 
of Vγ2+ γδT17 cells are caused by an increased thymic expansion 
of mature Vγ2+ γδT17 cells in ft/ft mice that would normally be 
10
Jee et al. Dysregulated Thymocyte Production in Filaggrin-Deficient Mice
Frontiers in Immunology | www.frontiersin.org May 2018 | Volume 9 | Article 988
restricted in some way by filaggrin in WT mice. However, we 
could conclude that the production of Vγ2+ γδT17 cells in the 
thymus of ft/ft mice is increased.
In conclusion, in this study, we establish that filaggrin is 
expressed in the thymic medulla of WT mice, and this expression 
is decreased at both the transcriptional and translational level 
in ft/ft mice. Furthermore, we show that there is an enhanced 
production Vγ2+ γδT17 cells in the thymus of filaggrin-deficient 
mice and that there is a general increase in the number of thymo-
cytes. Therefore, we suggest that reduced expression of filaggrin 
in the thymus affects the production of γδ T cells, which leads 
to increased IL-17 polarization. Currently, mutations in Flg are 
primarily associated with skin disease, but our results support 
that they might also cause systemic alterations in the immune 
system. This is supported by the observation that both humans 
and mice with filaggrin deficiency have systemically elevated 
levels of Th17  cells. As 8–10% of the European population are 
carriers of a filaggrin mutation, it is important to uncover still 
unknown effects of this mutation, and it will be very interesting to 
analyze whether humans with filaggrin deficiency have elevated 
numbers of γδT17 cells and if so whether they represent natural 
or inducible γδT17 cells.
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